Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · Real-Time Price · USD
66.61
-0.17 (-0.25%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Utah Medical Products Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 37.53 | 38.52 | 40.9 | 50.22 | 52.28 | 49.05 | Upgrade
|
| Revenue Growth (YoY) | -4.43% | -5.83% | -18.56% | -3.94% | 6.58% | 16.30% | Upgrade
|
| Cost of Revenue | 15.79 | 16.52 | 16.76 | 20.19 | 20.09 | 18.14 | Upgrade
|
| Gross Profit | 21.75 | 22 | 24.14 | 30.04 | 32.2 | 30.92 | Upgrade
|
| Selling, General & Admin | 8.91 | 8.58 | 7.6 | 12.7 | 11.91 | 11.51 | Upgrade
|
| Research & Development | 0.67 | 0.67 | 0.81 | 0.56 | 0.49 | 0.53 | Upgrade
|
| Operating Expenses | 9.58 | 9.24 | 8.41 | 13.26 | 12.41 | 12.04 | Upgrade
|
| Operating Income | 12.17 | 12.76 | 15.73 | 16.78 | 19.79 | 18.88 | Upgrade
|
| Interest & Investment Income | 2.81 | 2.81 | 3.37 | 3.04 | 0.66 | 0.17 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.02 | -0.02 | 0 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.17 | -0.08 | -0.16 | 0.28 | 0.21 | 0.02 | Upgrade
|
| EBT Excluding Unusual Items | 14.79 | 15.47 | 18.94 | 20.09 | 20.66 | 19.06 | Upgrade
|
| Legal Settlements | -1.36 | -1.36 | -2.14 | - | - | - | Upgrade
|
| Pretax Income | 13.43 | 14.11 | 16.8 | 20.09 | 20.66 | 19.06 | Upgrade
|
| Income Tax Expense | 2.58 | 2.82 | 2.93 | 3.45 | 4.19 | 4.27 | Upgrade
|
| Net Income | 10.85 | 11.29 | 13.87 | 16.64 | 16.47 | 14.79 | Upgrade
|
| Net Income to Common | 10.85 | 11.29 | 13.87 | 16.64 | 16.47 | 14.79 | Upgrade
|
| Net Income Growth | -16.28% | -18.65% | -16.60% | 0.98% | 11.39% | 36.95% | Upgrade
|
| Shares Outstanding (Basic) | 3 | 3 | 4 | 4 | 4 | 4 | Upgrade
|
| Shares Outstanding (Diluted) | 3 | 3 | 4 | 4 | 4 | 4 | Upgrade
|
| Shares Change (YoY) | -6.35% | -7.51% | -3.68% | -0.17% | -0.46% | -0.33% | Upgrade
|
| EPS (Basic) | 3.38 | 3.48 | 3.96 | 4.58 | 4.53 | 4.05 | Upgrade
|
| EPS (Diluted) | 3.38 | 3.48 | 3.96 | 4.57 | 4.52 | 4.04 | Upgrade
|
| EPS Growth | -10.62% | -12.06% | -13.33% | 1.11% | 11.88% | 37.41% | Upgrade
|
| Free Cash Flow | - | 14.32 | 14.6 | 21.64 | 20.34 | 20.65 | Upgrade
|
| Free Cash Flow Per Share | - | 4.42 | 4.17 | 5.95 | 5.58 | 5.64 | Upgrade
|
| Dividend Per Share | 1.230 | 1.225 | 1.205 | 1.185 | 1.165 | 0.855 | Upgrade
|
| Dividend Growth | 1.65% | 1.66% | 1.69% | 1.72% | 36.26% | -23.66% | Upgrade
|
| Gross Margin | 57.94% | 57.12% | 59.03% | 59.81% | 61.58% | 63.03% | Upgrade
|
| Operating Margin | 32.42% | 33.12% | 38.46% | 33.40% | 37.85% | 38.49% | Upgrade
|
| Profit Margin | 28.91% | 29.30% | 33.92% | 33.12% | 31.51% | 30.15% | Upgrade
|
| Free Cash Flow Margin | - | 37.18% | 35.70% | 43.09% | 38.90% | 42.10% | Upgrade
|
| EBITDA | 15.15 | 15.71 | 18.53 | 23.09 | 26.82 | 26.16 | Upgrade
|
| EBITDA Margin | 40.36% | 40.78% | 45.30% | 45.98% | 51.30% | 53.33% | Upgrade
|
| D&A For EBITDA | 2.98 | 2.95 | 2.8 | 6.32 | 7.03 | 7.28 | Upgrade
|
| EBIT | 12.17 | 12.76 | 15.73 | 16.78 | 19.79 | 18.88 | Upgrade
|
| EBIT Margin | 32.42% | 33.12% | 38.46% | 33.40% | 37.85% | 38.49% | Upgrade
|
| Effective Tax Rate | 19.24% | 20.01% | 17.43% | 17.19% | 20.26% | 22.42% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.